Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia

Cyclin-dependent kinase 9 and bromodomain and extraterminal inhibitors are synergistic in MLL-rearranged leukemia. Multiple AML driver genes are downregulated by the combined therapy suggesting broad applicability for this subtype.

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: McCalmont, Hannah, Li, Ka Leung, Jones, Luke, Toubia, John, Bray, Sarah C., Casolari, Debora A., Mayoh, Chelsea, Samaraweera, Saumya E., Lewis, Ian D., Prinjha, Rab K., Smithers, Nicholas, Wang, Shudong, Lock, Richard B., D’Andrea, Richard J.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Stimulus Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988396/
https://ncbi.nlm.nih.gov/pubmed/31971998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000586
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料